Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Escobar

Showing results (91-100 of 368) with videos related to

Pageof 37
Sort By:
Expert Review of Cardiovascular Therapy|September 18, 2007
Candesartan: from left ventricular hypertrophy to heart failure, a global approachVivencio Barrios, Carlos Escobar, Alberto Calderon
Journal of Clinical Hypertension (Greenwich, Conn.)|March 1, 2012
Aliskiren: a potential antiarrhythmic drug?Vivencio Barrios, Carlos Escobar, Alberto Calderon
European Journal of Internal Medicine|February 1, 2016
Therapeutic behavior of primary care physicians in patients with atrial fibrillation taking vitamin K antagonists not adequately controlledCarlos Escobar, Vivencio Barrios, Luis Prieto
Revista Espanola De Cardiologia (English Ed.)|June 4, 2021
Primary prevention. The cornerstone to reduce the burden of cardiovascular diseaseVivencio Barrios, Carlos Escobar, Maciej Banach
Medicina Clinica|August 6, 2021
[Direct oral anticoagulants today]Carlos Escobar Cervantes, Vivencio Barrios Alonso
Journal of Hypertension|May 21, 2009
Combined therapy in the treatment of hypertension: but which?Carlos Escobar, Rocio Echarri, Vivencio Barrios
American Journal of Hypertension|April 24, 2009
Treating heart rate for the prevention of diabetes: the next step?Carlos Escobar, Rocio Echarri, Vivencio Barrios
International Journal of Cardiology|June 19, 2009
Renal function and coronary disease: not only in clinical trialsCarlos Escobar, Rocio Echarri, Vivencio Barrios
Revista Espanola De Cardiologia|March 26, 2010
[Can the nephroprotective effect of N-acetylcysteine be optimized?]Vivencio Barrios, Carlos Escobar, Rocío Echarri
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|April 12, 2011
When kidney is the differenceVivencio Barrios, Carlos Escobar, Rocio Echarri
Pageof 37

Showing results (91-100 of 368) with videos related to

Sort By:
Pageof 37
Expert Review of Cardiovascular Therapy|September 18, 2007
Candesartan: from left ventricular hypertrophy to heart failure, a global approachVivencio Barrios, Carlos Escobar, Alberto Calderon
Journal of Clinical Hypertension (Greenwich, Conn.)|March 1, 2012
Aliskiren: a potential antiarrhythmic drug?Vivencio Barrios, Carlos Escobar, Alberto Calderon
European Journal of Internal Medicine|February 1, 2016
Therapeutic behavior of primary care physicians in patients with atrial fibrillation taking vitamin K antagonists not adequately controlledCarlos Escobar, Vivencio Barrios, Luis Prieto
Revista Espanola De Cardiologia (English Ed.)|June 4, 2021
Primary prevention. The cornerstone to reduce the burden of cardiovascular diseaseVivencio Barrios, Carlos Escobar, Maciej Banach
Medicina Clinica|August 6, 2021
[Direct oral anticoagulants today]Carlos Escobar Cervantes, Vivencio Barrios Alonso
Journal of Hypertension|May 21, 2009
Combined therapy in the treatment of hypertension: but which?Carlos Escobar, Rocio Echarri, Vivencio Barrios
American Journal of Hypertension|April 24, 2009
Treating heart rate for the prevention of diabetes: the next step?Carlos Escobar, Rocio Echarri, Vivencio Barrios
International Journal of Cardiology|June 19, 2009
Renal function and coronary disease: not only in clinical trialsCarlos Escobar, Rocio Echarri, Vivencio Barrios
Revista Espanola De Cardiologia|March 26, 2010
[Can the nephroprotective effect of N-acetylcysteine be optimized?]Vivencio Barrios, Carlos Escobar, Rocío Echarri
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|April 12, 2011
When kidney is the differenceVivencio Barrios, Carlos Escobar, Rocio Echarri
Pageof 37